Will Ethics Revive (Exhume?) the Drug Industry’s Reputation? Excellence in Ethics Accreditation Proposed for Pharma
We all know why the drug industry has a bad reputation. For one thing, it has been found guilty of unethical and even unlawful practices that include hiding clinical trial data and illegally marketing drugs. How to improve the industry’s reputation is a perrenial question.
So it was with great interest that I read about a new effort to improve the drug industry’s reputation: the establishment by a bioethicist of an accreditation rating system.
Jennifer Miller, a fellow at the Edmund J Safra Center for Ethics at Harvard University and president of Bioethics International, a non-profit that advises educational programs on ethical issues on medicine and healthcare, is trying to develop the industry equivalent of a “Good Housekeeping Seal of Approval.” This article summarizes her ideas and presents opinions of several naysayers.
Topics include:
- A Pharma Industry Seal of Approval
- Achilles’ Heel: Credibility of the Seal
- Excellence in Ethics Accreditation
- Volunteers Needed
Download the full text PDF file here:
http://ec2-54-175-84-28.compute-1.amazonaws.com/pharma-mkting.com/news/pmn1202-article03.pdf
PMN1202-03
Issue: Vol. 12, No. 2: 20 February 2013
